In trading on Monday, shares of Idexx Laboratories, Inc. (IDXX) touched a new 52-week high of $129.47/share. That's a 58.72% rise, or $47.9 per share from the 52-week low of $81.57 set back on 05/30/2013. That means at today's intraday high, any investor who purchased IDXX stock any time over the past 52 weeks has an unrealized gain, including company insiders.
Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, IDXX has seen 3 different instances of insiders buying over the trailing six month period.
|11/04/2013||M. Anne Szostak||Director||1,000||$108.24||$108,240.00|
|11/22/2013||Sophie V. Vandebroek||Director||1,000||$107.84||$107,840.00|
|12/12/2013||Robert J. Murray||Director||500||$102.31||$51,155.00|
|02/20/2014||M. Anne Szostak||Director||2,000||$126.71||$253,425.60|
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts